Nitric oxide synthase inhibition affects sarcoplasmic reticulum Ca2+ release in skeletal muscle fibres from mouse

Journal of Physiology

Volumn 567, Issue 3, 2005, Pages 815-828

  Pouvreau, Sandrine ^a   Jacquemond, Vincent ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE DERIVATIVE; CALCIUM CHANNEL; CALCIUM ION; DITHIOTHREITOL; HYDROGEN PEROXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; RYANODINE RECEPTOR; N(G) NITROARGININE; NITRIC OXIDE; S METHYLTHIOCITRULLINE;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM TRANSPORT; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ENZYME INHIBITION; MEMBRANE CURRENT; MEMBRANE DEPOLARIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE; VOLTAGE CLAMP; CELL MEMBRANE POTENTIAL; FLEXOR DIGITORUM BREVIS MUSCLE; OXIDATION REDUCTION REACTION; VOLTAGE CLAMP TECHNIQUE;

ANIMALS; CALCIUM; CITRULLINE; ENZYME INHIBITORS; HYDROGEN PEROXIDE; INDOLES; MEMBRANE POTENTIALS; MICE; MICE, INBRED STRAINS; MUSCLE FIBERS; MUSCLE, SKELETAL; NITRIC OXIDE SYNTHASE; NITROARGININE; SARCOPLASMIC RETICULUM; THIOUREA;

EID: 25844455230     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2005.089599     Document Type: Article

References (40)

1. 2+ release channel from oxidation induced activation. J Biol Chem 272, 25462-25467.
2. Alderton WK, Cooper CE & Knowles RG (2001). Nitric oxide synthases: structure, function and inhibition. Biochem J 357, 593-615.
3. 2+ activation of RyR1 channels. J Biol Chem 278, 42927-42935.
4. Baylor SM, Chandler WK & Marshall MW (1983). Sarcoplasmic reticulum calcium release in frog skeletal muscle fibres estimated from arsenazo III calcium transients. J Physiol 344, 625-666.
5. Baylor SM & Hollingworth S (1988). Fura-2 calcium transients in frog skeletal muscle fibres. J Physiol 403, 151-192.
6. Boer R, Ulrich WR, Klein T, Mirau B, Haas S & Baur I (2000). The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes. Mol Pharmacol 58, 1026-1034.
7. Collet C, Allard B, Tourneur Y & Jacquemond V (1999). Intracellular calcium signals measured with indo-1 in isolated skeletal muscle fibres from control and mdx mice. J Physiol 520, 417-429.
8. Collet C, Csernoch L & Jacquemond V (2003). Intramembrane charge movement and L-type calcium current in skeletal muscle fibers isolated from control and mdx mice. Biophys J 84, 251-265.
9. Collet C & Jacquemond V (2002). Sustained release of calcium elicited by membrane depolarization in ryanodine-injected mouse skeletal muscle fibers. Biophys J 82, 1509-1523.
10. Collet C, Pouvreau S, Csernoch L, Allard B & Jacquemond V (2004). Calcium signaling in isolated skeletal muscle fibers investigated under 'Silicone Voltage-Clamp' conditions. Cell Biochem Biophys 40, 225-236.
11. 2+ concentration in mouse skeletal muscle fibers with the fluorescent indicator mag-indo-1. Biophys J 75, 957-967.
12. 2+ release. J Physiol 526, 507-514.
13. Eu JP, Hare JM, Hess DT, Skaf M, Sun J, Cardenas-Navina I et al. (2003). Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide. Proc Natl Acad Sci U S A 100, 15229-15234.
14. 2 sensor and NO signaling functions. Cell 102, 499-509.
15. Eu JP, Xu L, Stamler JS & Meissner G (1999). Regulation of ryanodine receptors by reactive nitrogen species. Biochem Pharmacol 57, 1079-1084.
16. Gath I, Closs EI, Godtel-Armbrust U, Schmitt S, Nakane M, Wessler I & Forstermann U (1996). Inducible NO synthase II and neuronal NO synthase I are constitutively expressed in different structures of guinea pig skeletal muscle: implications for contractile function. FASEB J 10, 1614-1620.
17. Haarmann CS, Fink RH & Dulhunty AF (1999). Oxidation and reduction of pig skeletal muscle ryanodine receptors. Biophys J 77, 3010-3022.
18. Hart JDE & Dulhunty AF (2000). Nitric oxide activates or inhibits skeletal muscle ryanodine receptors depending on its concentration, membrane potential and ligand binding. J Membr Biol 173, 227-236.
19. 2+ current to β-adrenergic receptor stimulation via a C2 region-containing protein kinase C isoform. Circ Res 87, 1164-1171.
20. + channels by hypoxia. J Physiol 554, 743-754.
21. Ignarro LJ (2002). Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J Physiol Pharmacol 53, 503-514.
22. Jacquemond V (1997). Indo-1 fluorescence signals elicited by membrane depolarization in enzymatically isolated mouse skeletal muscle fibers. Biophys J 73, 920-928.
23. Klein MG, Simon BJ & Schneider MF (1990). Effects of caffeine on calcium release from the sarcoplasmic reticulum in frog skeletal muscle fibres. J Physiol 425, 599-626.
24. Kobzik L, Reid MB, Bredt DS & Stamler JS (1994). Nitric oxide in skeletal muscle. Nature 372, 546-548.
25. Massion PB, Feron O, Dessy C & Balligand JL (2003). Nitric oxide and cardiac function: ten years after, and continuing. Circ Res 93, 388-398.
26. Meszaros LG, Minarovic I & Zahradnikova A (1996). Inhibition of the skeletal muscle ryanodine receptor calcium release channel by nitric oxide. FEBS Lett 380, 49-52.
27. Park MK, Lee SH, Ho WK & Earn YE (1995). Redox agents as a link between hypoxia and the responses of ionic channels in rabbit pulmonary vascular smooth muscle. Exp Physiol 80, 835-842.
28. 2 sensitivity to Kv4.2 but not to Shaker channels. J Gen Physiol 113, 897-907.
29. Posterino GS, Cellini MA & Lamb GD (2003). Effects of oxidation and cytosolic redox conditions on excitation-contraction coupling in rat skeletal muscle. J Physiol 547, 807-823.
30. Pouvreau S, Allard B, Berthier C & Jacquemond V (2004). Control of intracellular calcium in the presence of nitric oxide donors in isolated skeletal muscle fibres from mouse. J Physiol 560, 779-794.
31. Reid MB (2001). Redox modulation of skeletal muscle contraction: what we know and what we don't. J Appl Physiol 90, 724-731.
32. Reid MB, Kobzik L, Bredt DS & Stamler JS (1998). Nitric oxide modulates excitation-contraction coupling in the diaphragm. Comp Biochem Physiol 119, 211-218.
33. Richmonds CR & Kaminski HJ (2001). Nitric oxide synthase expression and effects of nitric oxide modulation on contractility of rat extraocular muscle. FASEB J 15, 1764-1770.
34. Silvagno F, Xia H & Bredt DS (1996). Neuronal nitric-oxide synthase-mu, an alternatively spliced isoform expressed in differentiated skeletal muscle. J Biol Chem 271, 11204-11208.
35. Stamler JS & Meissner G (2001). Physiology of nitric oxide in skeletal muscle. Physiol Rev 81, 209-237.
36. Stoyanovsky D, Murphy T, Anno PR, Kim YM & Salama G (1997). Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium 21, 19-29.
37. Suko J, Drobny H & Hellmann G (1999). Activation and inhibition of purified skeletal muscle calcium release channel by NO donors in single channel current recordings. Biochim Biophys Acta 1451, 271-287.
38. Sun J, Xin C, Eu JP, Stamler JS & Meissner G (2001a). Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO. Proc Natl Acad Sci U S A 98, 11158-11162.
39. Sun J, Xu L, Eu JP, Stamler JS & Meissner G (2001b). Classes of thiols that influence the activity of the skeletal muscle calcium release channel. J Biol Chem 276, 15625-15630.
40. 2 in S-nitrosylation of the channel. J Biol Chem 278, 8184-8189.